Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
47,044,110
-
Shares change
-
-677,578
-
Total reported value, excl. options
-
$8,388,424,595
-
Value change
-
-$134,114,517
-
Put/Call ratio
-
488%
-
Number of buys
-
87
-
Number of sells
-
-105
-
Price
-
$178.30
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2023
251 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q2 2023.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,044,110 shares
of 1,385,160,313 outstanding shares and own 3.4% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11,668,897 shares), Capital International Investors (6,295,399 shares), HHLR ADVISORS, LTD. (5,176,906 shares), PRIMECAP MANAGEMENT CO/CA/ (5,014,649 shares), BAILLIE GIFFORD & CO (3,283,304 shares), Temasek Holdings (Private) Ltd (3,008,112 shares), FMR LLC (2,283,433 shares), Invesco Ltd. (1,558,371 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,484,874 shares), and Capital International, Inc./CA/ (919,436 shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.